Treatment

AZD9550 clinical trials

Active studies that list AZD9550 as an intervention or treatment.

3active studies

1recruiting now

7countries represented

15largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 1

Healthy ParticipantsCondition

AZD6234, Ethinyl estradiol/Levonorgestrel (EE/LEVO)Treatment

United States2 locations

AstraZenecaSponsor

Updated 2026-08-18 · NCT07013643See eligibility →

Active, not recruitingPhase 1, Phase 2

Overweight and ObesityCondition

AZD9550, placeboTreatment

Austria, Canada15 locations

AstraZenecaSponsor

Updated 2026-08-26 · NCT06151964See eligibility →

Active, not recruitingPhase 2

Obesity/OverweightCondition

AZD6234, PlaceboTreatment

China3 locations

AstraZenecaSponsor

Updated 2026-07-02 · NCT07017179See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.